When Standard Immunotherapy Doesn't Work, Try This Instead

When Standard Immunotherapy Doesn't Work, Try This Instead

Author: Dr. Dino Prato - Envita Medical Centers March 2, 2026 Duration: 18:55
In this episode, Dr. Dino Prato navigates the complexities of treating cancers that appear invisible to the immune system, making traditional immunotherapy for cancer less effective. He explains how building custom immunotherapies and changing tumor information can overcome these limitations, offering new avenues for cancer treatment. This discussion is crucial for anyone interested in advancements in oncology and how precision oncology is shaping the future of care, focusing on immune respo...

For anyone navigating a cancer diagnosis, the standard treatment path can feel both overwhelming and impersonal. OutSmart Cancer-Precision Oncology. Less Guess Work. More Life! moves beyond that generic approach, diving into the nuanced world of personalized medicine. Hosted by Dr. Dino Prato, founder of Envita Medical Centers, conversations here are built on a quarter-century of clinical experience helping patients for whom conventional protocols weren't enough. You'll hear detailed discussions that demystify complex topics like genomic testing, targeted therapies, and how integrative strategies can support the body during treatment. This isn't about promoting easy answers; it's about exploring the detailed, often overlooked factors that influence cancer progression and recovery. Each episode aims to translate cutting-edge science and hard-earned clinical wisdom into actionable knowledge, empowering you and your loved ones to ask better questions and understand the full spectrum of options. Tune in for a resource that treats your journey with the specificity it deserves, fostering informed dialogue between patients and their healthcare teams. This podcast serves as a guide for those determined to look deeper into their care, emphasizing a strategy tailored to the individual rather than the disease alone.
Author: Language: en-us Episodes: 50

OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!
Podcast Episodes
Cancer Survival Rates Are Misleading | Here's Why [not-audio_url] [/not-audio_url]

Duration: 11:12
In January 2026, the American Cancer Society announced a 70% cancer survival rate, a statistic that can be misleading to a cancer patient. Dr. Prato clarifies the nuances behind this data, emphasizing that while there's…
This New Cancer Device Just Got FDA Approval [not-audio_url] [/not-audio_url]

Duration: 8:22
A new device has received food and drug administration approval for pancreatic cancer, offering a new tool in cancer treatment. This wearable technology works by disrupting cancer cells, potentially slowing growth. While…